Changeflow GovPing Healthcare & Life Sciences APTA Alternative Peripheral TAVI Accesses Regis...
Routine Notice Added Final

APTA Alternative Peripheral TAVI Accesses Registry Observational Study

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

The NIH ClinicalTrials.gov registry records an observational multi-center study investigating alternative peripheral access routes for transcatheter aortic valve implantation (TAVI) in high and medium-risk patients with aortic stenosis who are contraindicated for transfemoral TAVI. The APTA registry will include patients treated at Upper Silesian Medical Center, Katowice and other hospitals.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The APTA (Alternative Peripheral TAVI Accesses) registry is a newly registered observational study on ClinicalTrials.gov under NIH. The study retrospectively and prospectively examines patients with aortic stenosis who cannot undergo standard transfemoral TAVI and are instead treated with transcatheter aortic valve implantation via peripheral access routes. The registry plans to enroll patients at Upper Silesian Medical Center in Katowice and additional hospital sites.

Affected parties include clinical research sites conducting TAVI procedures and patients with aortic stenosis who are candidates for alternative access approaches. The registry generates no immediate compliance obligations but establishes a structured data collection framework for outcomes associated with peripheral-access TAVI techniques.

Archived snapshot

Apr 21, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Alternative Peripheral TAVI Accesses

Observational NCT07539909 Kind: OBSERVATIONAL Apr 20, 2026

Abstract

The APTA (Alternative Peripheral TAVI Accesses) registry is an observational multi-center, retrospective and prospective study, including high and medium - risk patients with aortic stenosis (AS) contraindicates for trans-femoral TAVI, treated with TAVI thought to peripheral accesses. Upper Silesian Medical Center, Katowice and the other hospitals will be involved in the study.

Conditions: Aortic Stenosis

Interventions: TAVI procedures with an alternative access

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 20th, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Medical device research
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Medical Devices Pharmaceuticals

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!